MAPT and neurodegenerative disease: Plasma P-tau181 accurately discriminated Alzheimer’s disease dementia from non- Alzheimer’s disease neurodegenerative diseases with sensitivity and specificity similar to CSF Aβ42/Aβ40 and CSF T-tau, and slightly worse than CSF P-tau181 combined with Tau PET.